Study: Vaccine protects against oral HPV16/18 infection
The human papillomavirus vaccine affords strong protection against oral HPV16/18 infections, according to a new study in PLOS One. The findings suggest the vaccine may reduce the risk of HPV-positive oropharyngeal cancers, in particular HPV16, the type most commonly associated with this cancer.
(May require free registration to view article.)
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063